Myriad’s Direct-to-Consumer Ad Campaign Increases Sales Of Breast Cancer Gene Test
Myriad Genetics recently announced that its direct-to-consumer advertising campaign has increased sales of its breast cancer genetic test and that the company is considering expanding the campaign, the Wall Street Journal reports.
More: continued here
Filed under: Breast Cancer on February 8th, 2008